Both in Pharmaceuticals
Fortress Biotech vs Gain Therapeutics
Over the past year FBIO returned −43.6% and GANX returned −7.2%; their daily moves had a correlation of 0.14.
FBIO −43.6% GANX −7.2%Growth of $1, one year, split-adjusted
| Metric | FBIO | GANX |
|---|---|---|
| Price | $2.20 | $1.68 |
| Market cap | $73.4M | $73.3M |
| Today | +1.38% | −5.08% |
| 1 month | −20.6% | −5.1% |
| 6 months | −18.5% | −6.7% |
| Year to date | −39.9% | −47.8% |
| 1 year | −43.7% | −6.1% |
| Revenue growth (YoY) | +14.0% | — |
| Gross margin | 67.2% | — |
| Net margin | −13.2% | — |
| P/E (TTM) | 0.7× | — |
| Price / sales | 1.1× | — |
| Net cash | $157.0M | $12.7M |
| Dividend yield | — | — |
| Volatility (60d) | 60.9% | 63.5% |
| Short % of float | 19.9% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).